Marriage Counselors in Seabrook, NH Accepting Medicare

5 Marriage Counselors found. Showing 1 - 5

Ross Robert Randall, MFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 867 Lafayette Rd, Seabrook, NH 03874 Phone: 603-474-3332

Nicole Bouchard, MS Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 867 Lafayette Rd, Seabrook, NH 03874 Phone: 978-378-0830

Amber Kerby, M.S. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 867 Lafayette Rd, Seabrook, NH 03874 Phone: 603-474-3332

Sarah Marie Jones Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 867 Lafayette Rd, Seabrook, NH 03874 Phone: 603-474-3332

Jennifer Bostwick Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 867 Lafayette Rd, Seabrook, NH 03874 Phone: 978-358-1321

News Archive

Proteros, IP-K partner for structure-based drug discovery services in the field of infectious diseases

Proteros Biostructures GmbH announced today that it has entered into a service agreement with Institut Pasteur Korea (IP-K) under which Proteros will provide structure-based drug discovery services to IP-K.

Prototype drug halts GVHD in mouse models of bone marrow transplantation

A prototype drug already shown to hold promise for treating autoimmune disorders like lupus, arthritis and psoriasis halts established graft-versus-host disease (GVHD) in mouse models of bone marrow transplantation, research at the University of Michigan and the University of Florida shows.

Chemotherapy experts refute ASCO recommendations on use of drug sensitivity and resistance assays

A group of leading chemotherapy experts assembled as the Clinical Oncologists for Individualized Therapy (COFIT) refute the findings of the American Society of Clinical Oncology (ASCO) technology assessment panel regarding the use of chemotherapy sensitivity and resistance assays (CSRAs).

Pfizer Canada announces temporary suspension of Lipitor Continuity Card Program

The Regie d'Assurance Maladie du Quebec (RAMQ) recently advised Pfizer that they are examining all pharmaceutical card programs in Quebec. In light of this they have sent us a formal request dated June 16, 2010 to temporarily suspend the Lipitor Continuity Card Program. As part of our ongoing collaboration with the RAMQ, we have made the decision to temporarily suspend the distribution of the Lipitor Continuity Card in Quebec while they complete their analysis.

Researchers take first step in bioengineering human uterus to treat endometrial diseases

Researchers at Northwestern Medicine have taken the first step in bioengineering the human uterus to treat endometriosis, uterine-factor infertility and endometrial cancer.

Read more Medical News

› Verified 6 days ago